Description
About Niagen Bioscience Niagen Bioscience (NASDAQ: NAGE) is a global bioscience company on a mission to redefine healthy aging. Our scientists partner with leading universities and research institutions worldwide to discover, develop, and create solutions that positively impact human health and health-span. Our flagship ingredient, Niagen® nicotinamide riboside, is an NAD+ precursor backed by 45+ peer-reviewed, published clinical studies, 300+ global research collaborations, and over 500 human studies supporting NR, with over 75% of published studies using Niagen. Niagen is also on track to receive a USP monograph, further solidifying its gold standard position in the NAD+ category. Our brands include Tru Niagen®, a consumer supplement that safely and effectively increases NAD+, a vital cellular resource that supports healthy aging and cellular health, and NiagenTM Plus, our pharmaceutical-grade IV and injection products offered at wellness clinics nationwide and via healthcare practiti
Postuler
Publié 01/07/2026